Feng‐Ming Kong

机构：Queen Mary Hospital, Shenzhen Metro (China), University of Hong Kong - Shenzhen Hospital, University of Hong Kong · ORCID：0000-0003-2652-098X

发表论文 1319 篇 · 总被引 16607 次 · h-index 64

代表论文

• Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 43)
• Phocaeicola vulgatus induces immunotherapy resistance in hepatocellular carcinoma via reducing indoleacetic acid production (2025 · Cell Reports Medicine · 被引 11)
• Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma (2024 · Journal of the National Cancer Center · 被引 7)
• Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine (2025 · Advanced Science · 被引 5)
• A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028 (2025 · Frontiers in Immunology · 被引 4)
• Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints (2025 · Radiotherapy and Oncology · 被引 4)